Clinical study shows RenalGuard Therapy prevents post cardiac surgery AKI
RenalGuard system would better protect cardiopulmonary bypass (CPB) patients, undergoing cardiac surgery, from Acute Kidney Injury (AKI)
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Nov 19
RenalGuard system would better protect cardiopulmonary bypass (CPB) patients, undergoing cardiac surgery, from Acute Kidney Injury (AKI)
25 Oct 19
FMCNA’s new haemodialysis system has been designed to prevent blood clotting in patients without the use of blood…
23 Oct 19
Hatteras Venture Partners is a venture capital firm based in Durham, N.C., with a focus on seed and…
03 Oct 19
The Aquadex FlexFlow system is a clinically proven therapy that provides a safe, effective, and predictable method of…
13 Sep 19
Israeli digital health company Healthy.io has turned the smartphone-based ACR test into a clinical-grade medical device to detect…
30 Aug 19
Telix Japan is now permitted to commence a Phase I/II trial that is designed to bridge to the…
13 Aug 19
Benchmark’s world-class capabilities in the mass-production of FDA and ISO13485 certified medical devices position Quanta to meet the…
29 Jul 19
Quanta Dialysis Technologies, a UK-based medical technology company, has secured £38m ($48m) in a first closing of its…
US-based healthcare company CVS Health has initiated a clinical trial to evaluate the safety and efficacy of the…
12 Jul 19
Results showing arthroscopic surgery for knee problems is more accurate than MRI were presented at the Orthopedic Society…